online tender for the rate contract for the supply of medicines - nifedipine capsule (sublingual) 5 mg, disulfiram tablet 250 mg, methotrexate tablet 2.5 mg, phenobarbitone oral solution 20 mg/ 5 ml, 60 ml bottle, activated charcoal tablet 500 mg, acyclovir eye ointment 3%, 5 gm tube, phenytoin oral solution 25 mg/ml, 100 ml glass bottle, lignocaine jelly 2% w/v (with seprate nosal), 30gm tube, glyceryl trinitrate (sublingual) tablet 500 micrograms, levitiracetam oral solution, 100mg/ml, 100ml b

Haryana Medical Services Corporation Limited has invited bids for the online tender for the rate contract for the supply of medicines - nifedipine capsule (sublingual) 5 mg, disulfiram tablet 250 mg, methotrexate tablet 2.5 mg, phenobarbitone oral solution 20 mg/ 5 ml, 60 ml bottle, activated charcoal tablet 500 mg, acyclovir eye ointment 3%, 5 gm tube, phenytoin oral solution 25 mg/ml, 100 ml glass bottle, lignocaine jelly 2% w/v (with seprate nosal), 30gm tube, glyceryl trinitrate (sublingual) tablet 500 micrograms, levitiracetam oral solution, 100mg/ml, 100ml bottle, melatonin tablet 5 mg, natamycin eye drops 5% w/v, 5 ml, kojic acid cream 2 %, midazolam nasal spray 1.25 mg/spray, capsule venalafaxine extended release 37.5 mg, capsule venalafaxine extended release 75 mg, methylphenidate tablet 5 mg, olanzapine tablet 20 mg, tadalafil tablet/capsule 10 mg, paroxetine (cr) tablet 25 mg, breviteracetam tablet 50 mg, nicotin chewgum 2 mg, lacosamide tablet 100 mg, lithium carbonate tablet 300 mg, methyldopa tablet 250 mg, isosorbide mononitrate tablet 30 mg (sr), dienogest tablet 2 mg, ichthammol glycerine solution 10 ml vial, quetiapine tablet sr 100 mg, desvenlafaxine tablet 50 mg, pyridoxine tablet 10 mg, minoxidil solution 5%, 60ml bottle, vortioxetine tablet 10 mg, naxproxen (500mg)+ domperidone (10mg) tablet, estrogens cream 0.625 mg, 30gm tube, carbimazole tablet 5 mg, cyclopentolate eye drops 1% w/v, cabergoline tablet 0.5 mg, homatropine eye drops 1%, cinnarizine tablet 25 mg, medroxyprogesterone tablet 10 mg, tropicamide + phenylepherine eye drops 0.8% + 5%, 5 ml vial, saccharomyces boulardii 5 cfu sachets, ethinyestradiol tablet 5 mcg, simethicone syrup 40mg/ 5 ml, 60 ml bottle, hydroquinone 4%+ tretinoin 0.05% +fluocinolone 0.01 % skin cream, 15gm, voglibose 0.3 mg + metformin 500mg+ glimipride 1 mg tablet to various hospitals of government of haryana for a period of two years for group b medicines. The estimated project cost is ₹17.75 Cr, with an EMD of ₹0.02 Cr. Interested bidders can submit applications until 1 October 2026, with the technical opening scheduled for 1 October 2026.